Presentation TCT 2016 France Presents: How Did I Treat This Case? Presenter: Eric Van Belle, Jochen Wöhrle, Flavien Vincent October 30, 2016
Presentation TCT 2016 France Presents: A Patient With Critical CAD and Aortic Stenosis Undergoing TAVR: Staged or Single Procedure? Presenter: Eric Van Belle, Jochen Wöhrle, Flavien Vincent October 30, 2016
Presentation TCT 2016 Poland Presents: Treatment Options - Should Severe Coronary Artery Disease Be Treated Prior, During, or After TAVR (and in a Single or Staged Procedure)? Presenter: Eric Van Belle, Jochen Wöhrle, Dariusz Dudek October 30, 2016
Presentation TCT 2016 Introduction and Session Objectives Presenter: Eric Van Belle, Jochen Wöhrle October 30, 2016
Presentation TCT 2015 Paravalvular Regurgitation After TAVR 2: Importance of Valve Sizing and Calcium Patterns to Predict and Prevent Paravalvular Regurgitation After TAVR Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem, Jeffrey J. Popma October 15, 2015
Presentation TCT 2015 Paravalvular Regurgitation After TAVR 1: KEYNOTE LECTURE Diagnostic Considerations, Clinical Impact, and Treatment Alternatives Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem, Susheel Kodali October 15, 2015
Presentation TCT 2015 Stroke After TAVR 3: Controversy 2 Importance and Methods of Neurocognitive Functional Assessments Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem, Ronald M. Lazar October 15, 2015
Presentation TCT 2015 Stroke After TAVR 2: Controversy 1 Need for Cerebral Protection (Universal vs Selective) Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem October 15, 2015
Presentation TCT 2015 Stroke After TAVR 1: Reassessing Incidence (Declining), Etiologic Factors, and Remaining Controversies Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem October 15, 2015
Presentation TCT 2015 Assessing Postdevice Paravalvular Aortic Regurgitation Presenter: Jeroen J. Bax, Paul A. Grayburn, Rebecca T. Hahn October 15, 2015
Presentation TCT 2015 TCT 111: Impact of Concomitant Mitral Regurgitation Following Transcatheter Aortic Valve Replacement Insights From the US TVT National Registry Presenter: Steven R. Bailey, Patrick W. Serruys, Kreton Mavromatis October 15, 2015
News Conference News TCT 2015 Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves Todd Neale October 15, 2015
News Conference News TCT 2015 Low 1-Year Event Rates Seen After TAVR With Sapien 3 Todd Neale October 15, 2015
Presentation TCT 2015 TCT 106: Cardiovascular Magnetic Resonance for the Evaluation of Aortic Regurgitation Following Transcatheter Aortic Valve Replacement Insights on Clinical Outcomes Presenter: Michael J. Reardon, Torsten P. Vahl, Henrique Ribeiro October 13, 2015
Presentation TCT 2015 TCT 105: Transcatheter Aortic Valve Implantation Using a New Second-Generation TAVI System J-Valve for High-Risk Patients With Pure Aortic Regurgitation Presenter: Michael J. Reardon, Torsten P. Vahl, Yingqiang Guo October 13, 2015
News Conference News TCT 2015 Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored October 13, 2015
Presentation TCT 2015 Mild-to-Moderate Paravalvular Aortic Regurgitation After TAVR: Thoughtful Commentary on the Case Presenter: D. Craig Miller, Alec S. Vahanian, Samir R. Kapadia October 12, 2015
Presentation TCT 2015 Mild-to-Moderate Paravalvular Aortic Regurgitation After TAVR: Case Presentation Presenter: D. Craig Miller, Alec S. Vahanian, Anita Asgar October 12, 2015
Presentation TCT 2015 Aortic Stenosis and Mitral Regurgitation: Thoughtful Commentary on the Case (and MitraClip Considerations) Presenter: Robert O. Bonow, Allan Schwartz, Marco Barbanti October 12, 2015